Key Role of the Endothelial TGF-β/ALK1/Endoglin Signaling Pathway in Humans and Rodents Pulmonary Hypertension-Reference-Cited by-同舟云学术

Key Role of the Endothelial TGF-β/ALK1/Endoglin Signaling Pathway in Humans and Rodents Pulmonary Hypertension

Published:2014-06-23 Issue:6 Volume:9 Page:e100310
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gore Benoît,Izikki Mohamed,Mercier Olaf,Dewachter Laurence,Fadel Elie,Humbert Marc,Dartevelle Philippe,Simonneau Gerald,Naeije Robert,Lebrin Franck,Eddahibi Saadia

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT);N Galie;Eur Heart J,2009

2. Genetics and genomics of pulmonary arterial hypertension;RD Machado;J Am Coll Cardiol,2009

3. TGF-beta signal transduction;J Massague;Annu Rev Biochem,1998

4. Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways;MJ Goumans;Trends Cardiovasc Med,2003

5. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia;S Eddahibi;Circulation,2006

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management;International Journal of Molecular Sciences;2024-08-01

2. Endoglin and soluble endoglin in liver sinusoidal endothelial dysfunction in vivo;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03

3. Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future;Frontiers in Medicine;2024-01-17

4. Pharmacological Agents and Potential New Therapies in Pulmonary Arterial Hypertension;Current Vascular Pharmacology;2023-12-19

5. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension;Genetics in Medicine;2023-11